ASLAN001 in Patients With Advanced or Metastatic Cholangiocarcinoma Who Progressed on at Least 1 Line of Systemic Therapy
Clinical trial NCT02609958 · COMPLETED
Trial details
- NCT number
- NCT02609958
- Sponsor
- ASLAN Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-16
- Primary completion
- 2017-07-07
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.